Perkin Elmer – new member

Inovotion launches the first rapid in vivo evaluation test of therapeutic combination efficacy using PD1 / PD-L1 standard

With its expertise in early in vivo evaluation of efficacy in oncology, Inovotion has initiated an R&D program for developing a fast, reliable and perfectly predictive test for in vivo proof-of-concepts on synergistic treatments including checkpoint inhibitors, small molecule compounds, ADCs (Antibody Drug Conjugates), or even radiation therapy.

Read more

This is a unique website which will require a more modern browser to work!

Please upgrade today!